Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cabaletta Bio
Cabaletta Bio
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
CAR-T
Novartis
Cabaletta Bio
Cartesian Therapeutics
Bristol Myers Squibb
Gracell
Yake Biotechnology
A tale of two IPOs (plus one): Cabaletta prices well below range for $75M while Phathom bags $182M
Endpoints
Sat, 10/26/19 - 02:22 pm
IPOs
Cabaletta Bio
Phathom Pharmaceuticals
Cabaletta Bio Files for $100 Million IPO
CP Wire
Wed, 10/2/19 - 10:50 am
Cabaletta Bio
IPOs
autoimmune disease
DSG3-CAART
pemphigus vulgaris
Cabaletta Bio Files for $100 Million IPO
Wed, 10/2/19 - 09:42 am
Cabaletta Bio
DSG3-CAART
pemphigus vulgaris